Relaxation PM Sleep Blend Injectable 10mg/ml 10vials 1 kits

Description

Relaxation PM Sleep Blend DSIP Epitalon Injectable Research

Product Profile

The Relaxation PM Sleep formulation is a synergistic, multi-receptor peptide blend combining Delta Sleep-Inducing Peptide (DSIP) and Epithalon. [The blend modulates circadian rhythms]. This combination serves as a primary research benchmark for investigating the neuroendocrine regulation of sleep architecture and the dampening of sympathetic nervous system hyperactivity. Its dual-pathway design allows for high-fidelity studies on the restoration of slow-wave delta sleep phases.

Specification Sheet

• CAS Number: 62568-57-4 (DSIP) / 307297-39-8 (Epithalon)
• Molecular Formula: C35H48N10O15 (DSIP) / C14H22N4O9 (Epithalon)
• Molecular Weight: 848.8 g/mol / 390.3 g/mol
• Purity: >99.0% via HPLC-UV
• Appearance: Sterile white lyophilized powder cake

Mode of Action

The biochemical activity of this dual-peptide blend is defined by its concurrent engagement of the pineal gland and central nervous system neurotransmitter networks. At the molecular level, Epithalon interacts with the pineal gland to stimulate the endogenous transcription and release of melatonin. This defines the first semantic triple: [Epithalon stimulates pineal activity]. Secondly, DSIP crosses the blood-brain barrier and modulates GABAergic and glutamatergic transmission in the hypothalamus. This establishes the second triple: [DSIP modulates hypothalamic neurotransmitters]. Furthermore, this synchronized central nervous system signaling downregulates the HPA axis, significantly reducing nocturnal cortisol pulses. This forms the third triple: [Peptide signaling dampens sympathetic drive]. Quantitatively, while DSIP possesses a rapid systemic half-life of approximately 15 to 20 minutes ($t_{1/2}=18.0pm3.0$min) due to prompt aminopeptidase degradation, the resulting neuromodulatory cascade sustains altered sleep architecture for several hours. In comparative studies, this blend is distinguished from standalone exogenous Melatonin; while direct melatonin supplementation saturates receptors and downregulates endogenous production, the DSIP and Epithalon blend upregulates natural pineal secretion and modulates GABA-A receptors, facilitating a more sustainable, non-suppressive return to homeostatic sleep rhythms.

Experimental Outcomes

• Deepened Delta-Wave Sleep: Users in research models report profound increases in the duration and quality of restorative slow-wave sleep phases.
• Circadian Realignment: Published research indicates rapid adjustment of sleep-wake cycles, particularly beneficial following shift work or transmeridian travel.
• CNS Relaxation: Based on community feedback, research models show a marked reduction in pre-sleep cognitive arousal and physical tension.
• Neuroendocrine Reset: Cumulative findings indicate optimized nocturnal cortisol trajectories and improved next-day stress resilience.
• Enhanced Cellular Recovery: Research models have observed improved nocturnal tissue repair secondary to optimized endogenous repair mechanisms during deep sleep.

In Brief:
The Relaxation PM Sleep blend represents a premier research tool for investigating the synergistic modulation of circadian rhythms and the molecular pathways of restorative delta-wave sleep.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.